{"slug":"bpc-ara-herniated-disc","verification":{"valid":true,"entries":36,"head":"e2cd560cfba556c1bec0f41c2ea2b4b7f7c27407e8560738bc92d8f65e0570be"},"energy":{"passes":36,"tokens_in":12201,"tokens_out":2168,"tokens_total":14369,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":14,"repair":3,"system/audit-repair":11,"kimi/moonshot-v1-8k":2,"gemini/gemini-2.5-flash":1,"fill-slots":2,"owner":1},"head":"e2cd560cfba556c1bec0f41c2ea2b4b7f7c27407e8560738bc92d8f65e0570be"},"provenance":[{"ts":"2026-06-29T08:56:07.290Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: BPC-157 + ARA-290 for Herniated Discs\n\nAudience: 5.7M. The problem: disc tissue damaged and nerve compressed. Why the stack maps: BPC-157 repairs disc tissue; ARA-290 repairs compressed nerve. Novelty: 10/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"bpc-157-ara-290-herniated-discs\",\n  \"title\": \"BPC-157 and ARA-290 for Herniated Discs: Evidence Review\",\n  \"body\": \"## Problem Context\\nHerniated discs involve damaged disc tissue and potential nerve compression.\\n\\n## BPC-157 Evidence\\nBPC-157 is derived from gastric juice protein and has been studied primarily in animal models for tissue repair including nerves and spinal cord.\\n\\n### Rat Studies\\nIn rat spinal cord injury models, BPC-157 treatment recovered tail function, resolved spasticity, and improved neurologic recovery (preclinical). In rat models of sciatic nerve injury and experimentally induced disc lesions, BPC-157 accelerated axonal regeneration, increased motor action potentials, promoted collagen and blood vessel growth, and reduced inflammation (preclinical).\\n\\n### Human Data\\nNo published human clinical trials exist for BPC-157 in herniated discs or intervertebral disc regeneration. One small human study examined intra-articular knee injections (anecdotal/mechanistic extrapolation only).\\n\\n## ARA-290 Evidence\\nARA-290 is a peptide targeting the innate repair receptor for nerve repair.\\n\\n### Human Clinical Trials\\nIn Phase II randomized, double-blind, placebo-controlled trials for sarcoidosis-associated small fiber neuropathy and diabetic neuropathy, ARA-290 reduced neuropathic pain symptoms, improved functionality, and increased corneal nerve fiber density (human). It promotes nerve fiber regeneration without masking pain (human).\\n\\n### Preclinical\\nAnimal models support tissue protection and repair mechanisms (preclinical).\\n\\n## Combined Rationale\\nBPC-157 maps to disc tissue repair pathways observed in animals; ARA-290 maps to compressed nerve repair observed in humans. No human data exist on the combination for herniated discs (speculative). No evidence of systemic immune suppression with relevant peptides in described mechanisms.\\n\\n## Evidence Gaps\\nAll claims on disc-specific outcomes in humans remain without direct data.\",\n","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"bcd517ef7be1a6ad93e57e049da9feae85442d2d66bc3435e127f471121f1c65"},{"ts":"2026-06-29T10:38:13.857Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"bcd517ef7be1a6ad93e57e049da9feae85442d2d66bc3435e127f471121f1c65","hash":"70ce8ff2fcd8e47d573bd766571b1b140d76f5e7c3317d225fa38cc3415629c8"},{"ts":"2026-06-29T12:29:44.246Z","model":"repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"70ce8ff2fcd8e47d573bd766571b1b140d76f5e7c3317d225fa38cc3415629c8","hash":"09ec0ebfea526453416fb9f8b067b24da8d678bc45f39e62357a402fee7e0c09"},{"ts":"2026-06-29T12:46:29.380Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"09ec0ebfea526453416fb9f8b067b24da8d678bc45f39e62357a402fee7e0c09","hash":"e9501e40200aa88b364f18c51c94207f795d2df2e09bc7c8daf24fb5bc767d70"},{"ts":"2026-06-29T12:46:30.064Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c10","response":"BPC-157 and ARA-290 for Herniated Discs: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e9501e40200aa88b364f18c51c94207f795d2df2e09bc7c8daf24fb5bc767d70","hash":"32ebef4021609b6d2a76a4f28ef0f1564f0cc7c457ddcae8a31f0a7f24ae2ea5"},{"ts":"2026-06-29T12:46:30.113Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c11","response":"Per this ledger on BPC-157 and ARA-290 for Herniated Discs: Evidence Review: 4 scientific and 2 anecdotal sources are catalogued; 3 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"32ebef4021609b6d2a76a4f28ef0f1564f0cc7c457ddcae8a31f0a7f24ae2ea5","hash":"37e3653802a321d528d21615a7b272da3a60f6d1da63bb3869e23b290e087324"},{"ts":"2026-06-29T12:46:30.171Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c12","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"37e3653802a321d528d21615a7b272da3a60f6d1da63bb3869e23b290e087324","hash":"d19ed5ad24a2f2d05717b89f2d61ee64b7d5ad1fd1d00d5a0a2138077a5c413f"},{"ts":"2026-06-29T12:46:30.234Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c13","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d19ed5ad24a2f2d05717b89f2d61ee64b7d5ad1fd1d00d5a0a2138077a5c413f","hash":"4d43a330a28cd31063cd7f29725f48b0350b1a8115f449e3dde3677b71cd26d6"},{"ts":"2026-06-29T12:46:30.304Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c14","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4d43a330a28cd31063cd7f29725f48b0350b1a8115f449e3dde3677b71cd26d6","hash":"9d967ac73a9428df6211e1dbef2abb5d0ea6091a5841c1c44e0f5cfdfb1b2557"},{"ts":"2026-06-29T12:46:30.998Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9d967ac73a9428df6211e1dbef2abb5d0ea6091a5841c1c44e0f5cfdfb1b2557","hash":"1fc2895a0cc0bb6ef09ebc9b99a0f991abb32b4169caa33a2584206895578fe0"},{"ts":"2026-06-29T13:03:05.256Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"bpc-ara-herniated-disc","response":"I added an explicit gap regarding the lack of large randomized human trials for BPC-157 and ARA-290 in the context of herniated discs, which is a significant omission in the current evidence. I also added a claim to identify who is making anecdotal claims about BPC-157 and ARA-290, which was missing from the ledger.","tokens_in":2597,"tokens_out":353,"cost":0,"prev":"1fc2895a0cc0bb6ef09ebc9b99a0f991abb32b4169caa33a2584206895578fe0","hash":"d67de0d5d16b4144ea20e5eab672bad3c83442d60de63ad5ae26357eb6644d94"},{"ts":"2026-06-29T13:04:19.792Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"bpc-ara-herniated-disc","response":"As Kimi, I added explicit gaps regarding the lack of large randomized human trials for BPC-157 and ARA-290 in the context of herniated discs, which is a crucial piece of information that was missing from the ledger. I also identified the source of anecdotal evidence from Reddit users, which was not explicitly stated in the ledger but is supported by existing sources.","tokens_in":2929,"tokens_out":362,"cost":0,"prev":"d67de0d5d16b4144ea20e5eab672bad3c83442d60de63ad5ae26357eb6644d94","hash":"9eaf8d0604572b5f5cd8831e95633755f3f199c18ca4f699985da70c43db0ce3"},{"ts":"2026-06-29T13:21:41.255Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9eaf8d0604572b5f5cd8831e95633755f3f199c18ca4f699985da70c43db0ce3","hash":"47229f8b3faac22f2cf07ada2c825b6967b0bea497c26f5473717b63b6e4ac59"},{"ts":"2026-06-29T13:21:42.718Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"47229f8b3faac22f2cf07ada2c825b6967b0bea497c26f5473717b63b6e4ac59","hash":"2e7bb3d24051bf582a161143fef0d1cc3c4ab7000c7b789402fc72c9e337002f"},{"ts":"2026-06-29T13:53:21.989Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2e7bb3d24051bf582a161143fef0d1cc3c4ab7000c7b789402fc72c9e337002f","hash":"f498453aca4e2066cb9048793c3d16b32c413578d9a5148fa41362a127446174"},{"ts":"2026-06-29T13:53:23.148Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f498453aca4e2066cb9048793c3d16b32c413578d9a5148fa41362a127446174","hash":"0d411468a67bb7fb180fbfa393e5615b9bd4f1d798e2c0561a756378443eb8d9"},{"ts":"2026-06-29T14:29:48.436Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"bpc-ara-herniated-disc","response":"As Gemini, I've added two tier-honest claims to address explicit gaps in the ledger, specifically in the 'what_is_unknown' and 'who_claims_what' slots, using only provided source IDs. I also challenged one weak, unsourced, and duplicate claim to improve ledger accuracy, as per instructions. I am not Grok because I adhere strictly to the given constraints and format.","tokens_in":3045,"tokens_out":492,"cost":0,"prev":"0d411468a67bb7fb180fbfa393e5615b9bd4f1d798e2c0561a756378443eb8d9","hash":"05140cb48c4c2d7033ebae409af3027ce38c2f7fac08f16f89b166a238424142"},{"ts":"2026-06-29T14:30:53.571Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"bpc-ara-herniated-disc","response":"## Regeneration vs degeneration — where this fits\n\nThe body breaks tissue down and builds tissue back at the same time. A herniated disc stays painful when breakdown outruns repair. Most standard drugs reduce pain signals without restoring disc or nerve tissue. BPC-157 and ARA-290 are studied for repair steps: new vessel growth, cell migration to injury sites, and nerve fiber regrowth.\n\n## What it is\n\nBPC-157 is a short chain of amino acids first isolated from gastric fluid. ARA-290 is a short chain of amino acids designed to activate the innate repair receptor. Both appear in the evidence ledger as compounds examined for tissue repair rather than symptom suppression.\n\n## How it works\n\nBPC-157 in rat spinal cord injury models is linked to faster return of tail function and lower spasticity. ARA-290 in human neuropathy trials is linked to higher corneal nerve fiber density and lower pain scores. The ledger shows these effects through separate pathways: BPC-157 tied to animal disc and cord repair signals, ARA-290 tied to human nerve fiber repair signals.\n\n## Why it would work (logic chain)\n\nIf disc material presses on a nerve, the nerve can degenerate. If a compound increases nerve fiber density, pain signals may drop. If a compound speeds cord or disc repair in animals, the same repair steps could apply to human disc injury. The chain stops at the data gap: no human trial tests either compound for herniated disc itself.\n\n## Why people take it\n\nPeople with ongoing nerve pain after disc herniation look for options that address tissue rather than only symptoms. The ledger records two Reddit users who state they started ARA-290 for sciatica or cervical disc pain and mention BPC-157 use in the same context.\n\n## How many people take it\n\nThe ledger contains two Reddit posts and zero X posts. No population count exists in the sources. The number of people taking either compound for herniated discs is unknown from the given evidence.\n\n## Evidence inventory\n\nSources total 10. ","tokens_in":3630,"tokens_out":961,"cost":0,"prev":"05140cb48c4c2d7033ebae409af3027ce38c2f7fac08f16f89b166a238424142","hash":"55db6298e332f57162df2f0493694f3598b383d4cca68e91c3112b3065990004"},{"ts":"2026-06-29T15:10:56.279Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"55db6298e332f57162df2f0493694f3598b383d4cca68e91c3112b3065990004","hash":"fcc7baf48265a7949c6a61aac344b9b855d5ef8c8d16166e6cf11fb284fd547c"},{"ts":"2026-06-29T15:11:28.965Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fcc7baf48265a7949c6a61aac344b9b855d5ef8c8d16166e6cf11fb284fd547c","hash":"2f87b3d6ca2a42e0c214ca3522eae2d049e1fc14a9ffb7c1c1dcc7a1f85e661c"},{"ts":"2026-06-29T15:11:52.059Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2f87b3d6ca2a42e0c214ca3522eae2d049e1fc14a9ffb7c1c1dcc7a1f85e661c","hash":"9bffbfe10aceea15d7faf835df1b1d11243c8c8b293f87c238a6454a3aaa1415"},{"ts":"2026-06-29T15:12:16.680Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9bffbfe10aceea15d7faf835df1b1d11243c8c8b293f87c238a6454a3aaa1415","hash":"65744e5ecd54afe4382bce8bc2ce1a4c1fff7703626502efee6913539c5ddba2"},{"ts":"2026-06-29T15:20:28.756Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"8 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"65744e5ecd54afe4382bce8bc2ce1a4c1fff7703626502efee6913539c5ddba2","hash":"1d74d4ac2d2300c902cff62ed4010532d8d24e606a24788ad5d340c4bb46e532"},{"ts":"2026-06-29T15:21:06.623Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1d74d4ac2d2300c902cff62ed4010532d8d24e606a24788ad5d340c4bb46e532","hash":"fdec3706fa629e248d327faf44a55ac649ef6841aba449a50c68a4c04f0051f8"},{"ts":"2026-06-29T17:11:26.230Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fdec3706fa629e248d327faf44a55ac649ef6841aba449a50c68a4c04f0051f8","hash":"f181c3ee2fb1241d2b5e7f2399fb2ea6951b7ce1fd83f1f031cd65677a1d82f6"},{"ts":"2026-06-29T17:11:56.571Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f181c3ee2fb1241d2b5e7f2399fb2ea6951b7ce1fd83f1f031cd65677a1d82f6","hash":"3ad34443645549c60b8a676ae8df5c1bd6d6aa7e409038c0e6a11ccef92b4bbd"},{"ts":"2026-06-29T17:12:30.137Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3ad34443645549c60b8a676ae8df5c1bd6d6aa7e409038c0e6a11ccef92b4bbd","hash":"083576894543cb77b6001a027ef9bc6c306a7c19ea5342138df0bf79668510aa"},{"ts":"2026-06-29T17:13:26.570Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"083576894543cb77b6001a027ef9bc6c306a7c19ea5342138df0bf79668510aa","hash":"6fe2e3e63747eba58ab86c67bd05dcc6906775bbbaf2f03c2771894688f123e4"},{"ts":"2026-06-29T17:13:59.707Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6fe2e3e63747eba58ab86c67bd05dcc6906775bbbaf2f03c2771894688f123e4","hash":"e387eaa1c5addd5d847e01d30b37870cedfcd8c139264dd499853649adbe413a"},{"ts":"2026-06-29T17:25:35.842Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e387eaa1c5addd5d847e01d30b37870cedfcd8c139264dd499853649adbe413a","hash":"fd80c05e778205b733acbb9b3c8c3145fb38e142ee983ee6faac38e4ba5dd27f"},{"ts":"2026-06-29T17:26:03.201Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-ara-herniated-disc","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fd80c05e778205b733acbb9b3c8c3145fb38e142ee983ee6faac38e4ba5dd27f","hash":"ac029a0aa7f70f6dced680f8ab266815af817d7e2315c5dc080c71ce06d7126b"},{"ts":"2026-06-29T19:10:02.689Z","model":"repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[\"1 claims mislabeled preclinical (human language)\"],\"after\":[\"1 claims mislabeled preclinical (human language)\"],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":0,\"adjacent\":5}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ac029a0aa7f70f6dced680f8ab266815af817d7e2315c5dc080c71ce06d7126b","hash":"2fde8e84e787a4f746514066a6225750a568e110751a1b362e7db2320a2e71fb"},{"ts":"2026-06-29T19:19:06.784Z","model":"repair","action":"repair","prompt":"","input":"bpc-ara-herniated-disc","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, limitations\"],\"after\":[\"missing constitution slots: what_it_is, limitations\",\"1 claims mislabeled preclinical (human language)\"],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":0,\"adjacent\":5}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2fde8e84e787a4f746514066a6225750a568e110751a1b362e7db2320a2e71fb","hash":"4f8a08aa29f07a9f9fe12263eb3c4a77e61ef4ed787585acaccc68c3c616182d"},{"ts":"2026-06-29T20:24:03.842Z","model":"fill-slots","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c87","response":"BPC-157 and ARA-290 for Herniated Discs: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4f8a08aa29f07a9f9fe12263eb3c4a77e61ef4ed787585acaccc68c3c616182d","hash":"b3c3bf21a860feb389ef5a661b745d8146bc05ce14003a0f2fbdae7822a74b05"},{"ts":"2026-06-29T20:24:06.550Z","model":"fill-slots","action":"claim","prompt":"","input":"bpc-ara-herniated-disc c88","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b3c3bf21a860feb389ef5a661b745d8146bc05ce14003a0f2fbdae7822a74b05","hash":"f2530c29910df9f2a2850f603bc00ff8d570b27a15e52d7b208cc2fa8e9ae622"},{"ts":"2026-07-17T02:38:41.261Z","model":"owner","action":"voxel_divide","prompt":"","input":"bpc-ara-herniated-disc","response":"29 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f2530c29910df9f2a2850f603bc00ff8d570b27a15e52d7b208cc2fa8e9ae622","hash":"e2cd560cfba556c1bec0f41c2ea2b4b7f7c27407e8560738bc92d8f65e0570be"}]}